- ICH GCP
- Amerikanska kliniska prövningsregistret
- Klinisk prövning NCT07255092
Mekanismer som ligger till grund för nociboeffekten av smittande klåda. Både histaminerg och icke-histaminerg klåda.
Smärta och klådaneuromodulering: Effekter av offsetanalgesi, placebo och nocebo samt topografisk fördelning av klåda- och smärtreceptorer
The study consists of one experimental session of approximately 1½ hours. The participant will fill in a series of questionnaires about how you perceive itch and pain, and about some traits of your personality, such as depression, anxiety and stress. Afterwards, three areas will be selected on each forearm of the subjects.
Two areas will be treated with histamine, two with cowhage, and two with vehicle. One application of each substance will be conducted including the contagious itch component. During the 10 minutes of the application of the pruritogens, itch and pain will be continuously monitored using a VAS scale.
Studieöversikt
Status
Betingelser
Intervention / Behandling
Studietyp
Inskrivning (Beräknad)
Fas
- Inte tillämpbar
Kontakter och platser
Studiekontakt
- Namn: Silvia Lo Vecchio, PhD
- Telefonnummer: +4521397785
- E-post: slv@hst.aau.dk
Studieorter
-
-
Denmark
-
Gistrup, Denmark, Danmark, 9620
- Rekrytering
- Aalborg University
-
Kontakt:
- Silvia Lo Vecchio, PhD
- Telefonnummer: 21397785
- E-post: slv@hst.aau.dk
-
Kontakt:
- Giulia Erica Aliotta, PhD
- E-post: gea@hst.aau.dk
-
-
Deltagandekriterier
Urvalskriterier
Åldrar som är berättigade till studier
Tar emot friska volontärer
Kön som är behöriga för studier
Beskrivning
Inclusion Criteria:
- 18-60 years
- Speak and understand English
Exclusion Criteria:
- Pregnancy or lactation
- Drug addiction defined as any use of cannabis, opioids, or other drugs
- Previous or current history of neurological, immunological, musculoskeletal, cardiac disorder or psychiatric diagnoses that may affect the results (e.g., neuropathy, muscular pain in the upper extremities, anxiety, depression, schizophrenia, etc.)
- Moles, wounds, scars, or tattoos in the area to be treated or tested
- Current use of medications that may affect the trial such as antihistamines and pain killers
- Skin diseases
- Consumption of alcohol or painkillers 24 hours before the study days and between these
- Acute or chronic pain and itch
- Participation in other trials within 1 week of study entry (4 weeks in the case of pharmaceutical studies)
- Contraindications to capsaicin, including intolerance to chili or burns or wounds at the application site
- The subject is assessed as unable to engage in the necessary cooperation required by the study
Studieplan
Hur är studien utformad?
Designdetaljer
- Primärt syfte: Grundläggande vetenskap
- Tilldelning: N/A
- Interventionsmodell: Enskild gruppuppgift
- Maskning: Ingen (Open Label)
Vapen och interventioner
Deltagargrupp / Arm |
Intervention / Behandling |
|---|---|
|
Experimentell: Contagious itch
A contagious itch will be induced by a video (without audio) showing people scratching. |
To deliver histamine, standard allergy skin prick test (SPT) lancets are applied The spicules will be manually inserted. Approximately 30-35 spicules are gently rubbed into a 1 cm diameter skin area on the forearm/face To deliver steril water, standard allergy skin prick test (SPT) lancets are applied |
Vad mäter studien?
Primära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
|---|---|---|
|
Measuring pain by computerized Visual Analog Scale Scoring
Tidsram: Immediately after the intervention
|
The investigators will ask the subjects to rate the sensation of pain on a 100 mm VAS scale ranging from 0 to 100 where 0 indicates" no pain" and 100 indicates "worst pain imaginable". |
Immediately after the intervention
|
|
Measuring itch by computerized Visual Analog Scale Scoring
Tidsram: Immediately after the intervention
|
The investigators will ask the subjects to rate the sensation of itch on a 100 mm VAS scale ranging from 0 to 100 where 0 indicates "no itch" and 100 indicates "worst itch imaginable". |
Immediately after the intervention
|
Sekundära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
|---|---|---|
|
Pain Catastrophizing Scale (PCS).
Tidsram: Baseline
|
The PCS assesses negative and exaggerated coping concerning anticipated or experienced painful stimuli. Thirteen items have to be answered on a 5-point Likert-type scale ranging from 0 (Not at all) to 4 (all the time). |
Baseline
|
|
Learned Helplessness Scale (LHS)
Tidsram: Baseline
|
The questionnaire consists of 20 items, and the participant's response to each item is rated on a 4-point Likert scale ranging from strongly agree (1) to strongly disagree (4). |
Baseline
|
|
Depression, Anxiety, Stress Scale (DASS-21)
Tidsram: Baseline
|
The questionnaire measures the magnitude of depression, anxiety, and stress. Each of these three subscales consists of 7 questions answered using a 0-3 Likert scale, with 0 meaning "it did not apply to me", and 3 meaning "it applied to me very much" |
Baseline
|
|
Emotion Regulation Questionnaire (ERQ)
Tidsram: Baseline
|
This questionnaire is designed to assess individual differences in the habitual use of two emotion regulation strategies: cognitive reappraisal and expressive suppression. Respondents answer each item on a 7-point Likert-type scale ranging from 1 (strongly disagree) to 7 (strongly agree), where 4 means (neutral). |
Baseline
|
|
Itch Catastrophizing Scale (ICS)
Tidsram: Baseline
|
The ICS assesses negative and exaggerated coping concerning anticipated or experienced itchy stimuli. Thirteen items have to be answered on a 5-point Likert-type scale ranging from 0 (Not at all) to 4 (all the time). |
Baseline
|
|
Reinforcement Sensitivity Theory - Personality Questionnaire (RST-PQ).
Tidsram: Baseline
|
The RST-PQ contains in total 65 items must be answered on a 4-point Likert (Strongly disagree → Strongly agree) |
Baseline
|
|
Positive And Negative Affect Schedule (PANAS)
Tidsram: Baseline
|
Twenty words are associated with the subject's current feelings and have to be rated on a 5-points Likert-type scale from very slightly or not at all to extremely |
Baseline
|
|
Difficulties in Emotion Regulation Scale Short Form (DERS-SF)
Tidsram: Baseline
|
The questionnaire is an 18-item measure used to identify emotional regulation issues in adults. Participants rate each item on a 5-point Likert scale (from 1 to 5) from almost never to almost always |
Baseline
|
Samarbetspartners och utredare
Sponsor
Studieavstämningsdatum
Studera stora datum
Studiestart (Faktisk)
Primärt slutförande (Beräknad)
Avslutad studie (Beräknad)
Studieregistreringsdatum
Först inskickad
Först inskickad som uppfyllde QC-kriterierna
Första postat (Faktisk)
Uppdateringar av studier
Senaste uppdatering publicerad (Faktisk)
Senaste inskickade uppdateringen som uppfyllde QC-kriterierna
Senast verifierad
Mer information
Termer relaterade till denna studie
Ytterligare relevanta MeSH-villkor
Andra studie-ID-nummer
- N-20250017 Project 3
Läkemedels- och apparatinformation, studiedokument
Studerar en amerikansk FDA-reglerad läkemedelsprodukt
Studerar en amerikansk FDA-reglerad produktprodukt
Denna information hämtades direkt från webbplatsen clinicaltrials.gov utan några ändringar. Om du har några önskemål om att ändra, ta bort eller uppdatera dina studieuppgifter, vänligen kontakta register@clinicaltrials.gov. Så snart en ändring har implementerats på clinicaltrials.gov, kommer denna att uppdateras automatiskt även på vår webbplats .